Association between Treatment for Localized Prostate Cancer and Mental Health Outcomes
- Amy N. Luckenbaugh,
- Christopher J.D. Wallis,
- Li Ching Huang,
- Daniela Wittmann,
- ,
- Zighuo Zhao
- Vanderbilt University,
- University of Michigan, Ann Arbor,
- ,
- ,
- University of Texas at Austin,
- Emory University
Open access
Sustainable Development Goals
- SDG 3 Good Health and Well
Abstract
Results: A total of 2,742 men (median [quartiles] age 64 [59e70]) met inclusion criteria. Baseline depressive symptoms, as measured by the CES-D, were low (median 4, quartiles 1e8) without differences between groups. We found no effect of treatment modality on depressive symptoms (p[0.78), though older age, poorer health, being unmarried and baseline CES-D score were associated with declines in mental health. There was no clinically meaningful association between treatment modality and scores for either emotional well-being (p[0.81) or energy/fatigue (p[0.054). Conclusions: This prospective, population-based cohort study of men with localized prostate cancer showed no clinically important differences in mental health outcomes including depressive symptoms, emotional well-being, and energy/fatigue according to the treatment received (surgery, radiotherapy, or surveillance). However, we identified a number of characteristics associated with worse mental health outcomes including: older age, poorer health, being unmarried, and baseline CES-D score which may allow for early identification of patients most at risk of these outcomes following treatment.
Publication Information
Output type
Original language
English (US)Pages from-to (Number of pages)
Pages 1029-1037 (9 pages)Journal (Volume, Issue Number)
Journal of Urology (Volume 207, Issue 5)Publication milestones
- Published - 05/01/2022
Publication status
ISSN
0022-5347Publication IDs
- Scopus: 85128250964
- PubMed: 34978488
